Innovex International, Inc. INVX
28.50
(0.06)
(0.21%)
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 32.0×
Follow INVX
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
27.87 | 32.52 | 18.23 | 12.61 |
+8 more quarters Free account |
P/S ratio |
1.71 | 1.72 | 1.54 | 1.34 | |
P/FCF ratio |
7.71 | 6.86 | 5.90 | 5.29 | |
P/Operating CF |
46.08 | 84.75 | 28.89 | 26.37 | |
P/B ratio |
1.61 | 1.63 | 1.43 | 1.23 | |
Price to Tangible BV |
2.04 | 2.05 | 1.79 | 1.55 | |
EV/Sales |
1.51 | 1.54 | 1.36 | 1.19 | |
EV/EBITDA |
8.54 | 9.17 | 6.46 | 5.60 | |
EV/Operating CF |
9.58 | 8.38 | 6.97 | 6.51 | |
EV/FCF |
6.82 | 6.14 | 5.20 | 4.73 | |
Quick Ratio |
2.93 | 3.02 | 2.98 | 2.58 | |
Current Ratio |
5.01 | 5.10 | 4.91 | 4.78 | |
Net Debt/EBITDA |
(3.69) | 78.13 | (3.99) | (1.69) | |
Debt/Assets |
1.89% | 1.88% | 2.02% | 2.11% | |
Debt/Equity |
0.02 | 0.02 | 0.02 | 0.03 | |
Asset Turnover |
0.78 | 0.79 | 0.79 | 0.80 | |
Operating CF/Net income |
1.48 | (1.19) | 3.74 | 1.23 | |
Capex/Depreciation |
(0.06) | (0.29) | (0.40) | 4.18 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.96% | 17.47% | 11.71% | 14.82% | |
Intangible Assets out of Total Assets |
0.17 | 0.16 | 0.17 | 0.17 | |
Share Based Compensation of Revenue |
1.38% | 1.24% | 1.84% | 1.35% | |
Graham Net Nets |
0.30 | 0.30 | 0.34 | 0.39 | |
Graham Number |
17.55 | 15.89 | 20.34 | 22.35 | |
Earnings Yield |
3.59% | 3.08% | 5.49% | 7.93% | |
Free Cash Flow Yield |
12.97% | 14.57% | 16.95% | 18.89% | |
Revenue per Share |
3.56 | 3.47 | 3.96 | 3.49 | |
Operating CF per Share |
0.54 | 0.29 | 0.76 | 0.70 | |
Capex per Share |
(0.02) | (0.08) | (0.11) | 1.13 | |
Free Cash Flow per Share |
0.52 | 0.21 | 0.65 | 1.84 | |
Cash per Share |
3.23 | 2.91 | 2.95 | 2.37 | |
Shareholders Equity per Share |
15.39 | 14.95 | 15.33 | 15.10 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
15.39 | 14.95 | 15.33 | 15.10 | |
Free Cash Flow |
35.85 | 14.22 | 44.78 | 126.43 | |
Working Capital |
631.01 | 605.13 | 579.88 | 561.64 | |
Capital Expenditures |
(1.18) | (5.62) | (7.46) | 78.06 | |
Net Current Asset Value |
519.28 | 496.12 | 517.44 | 495.40 | |
EV/EBIT |
15.09 | 16.92 | 10.04 | 8.52 | |
Capex to Sales |
0.00 | 0.02 | 0.03 | (0.33) | |
Net Profit Margin |
10.22% | (6.97%) | 5.11% | 16.35% | |
Price to Operating Income |
17.06 | 18.90 | 11.38 | 9.54 | |
| Other line items | |||||
Average Receivables |
230.53 | 240.83 | 238.64 | 222.74 | |
Average Payables |
71.25 | 75.64 | 62.96 | 75.12 | |
Average Inventory |
271.67 | 261.12 | 259.80 | 286.36 | |
Average Assets |
1,277.41 | 1,241.84 | 1,232.90 | 1,193.35 | |
Average Common Equity |
1,027.03 | 1,004.64 | 1,007.93 | 971.65 |
Columns are period end dates